Graham Holdings Company Common Stock vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Graham Holdings Company Common Stock trades at $1,186.01 (market cap $4.97B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock is far larger — about 2.2× Graham Holdings Company Common Stock's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays the higher dividend (0.65%). Which is the better fit depends on your goals — on Pluang, investors hold Graham Holdings Company Common Stock for 0 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.
| GHC | RDY | |
|---|---|---|
Market Cap | $4.97B | $10.78B |
Volume | 27,383 | 2,724,343 |
Sector | Industrials | Health |
52-Week High | $1.23K | $15.38 |
52-Week Low | $949.84 | $11.38 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.06B | $10.68B |
Dividend Yield | 0.64% | 0.65% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Graham Holdings Company is a diversified holding company with operations spanning education services (Kaplan), television broadcasting (Graham Media Group), healthcare services, and manufacturing, among other businesses; it was formerly known as The Washington Post Company.
Read more on GHC →Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →